[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352297-105":59,"doc-detail-352297-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-level-of-antibodies-to-tumor-associated-glycans-in-gastric-cancer-patients-is-lower-than-in-healthy-donors-and-reduces-with-age","The Level of Antibodies to Tumor-Associated Glycans in Gastric Cancer Patients Is Lower than in Healthy Donors and Reduces with Age","","A study compares antibody levels against tumor-associated carbohydrate antigens in 235 treatment-naïve gastric cancer patients (stages I–IV) and 76 healthy donors using a printed glycan array. Anti-glycan IgM levels, but not IgG, decline with age in both groups. IgM levels against most glycans are significantly lower in the gastric cancer cohort even after age adjustment. Immunohistochemistry shows anti-GalNAcα (Tn) antibodies bind tumor cells and display staining patterns on non-tumor surface cells within the same organ, supporting immunodeficiency in gastric cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-level-of-antibodies-to-tumor-associated-glycans-in-gastric-cancer-patients-is-lower-than-in-healthy-donors-and-reduces-with-age/352297/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-level-of-antibodies-to-tumor-associated-glycans-in-gastric-cancer-patients-is-lower-than-in-healthy-donors-and-reduces-with-age/352297.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were anti-tumor glycan antibodies measured in the study?","Question",{"text":112,"@type":113},"The study analyzed antibody levels against tumor-associated carbohydrate antigens in gastric cancer patients and healthy donors using a printed glycan array.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which antibody class changes with age, and how does it differ between patients and donors?",{"text":117,"@type":113},"Anti-glycan IgM levels, but not IgG, reduce with age in both patients and donors; most IgM specificities are significantly lower in gastric cancer patients even after age adjustment.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the immunohistochemistry results suggest about Tn antibodies in gastric cancer?",{"text":121,"@type":113},"Anti-GalNAcα (Tn) antibodies bound tumor cells and showed perinuclear and membrane staining in non-tumor surface cells within the same organ, supporting reduced anti-glycan IgM involvement in early recognition of transformed cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352297,1790652010,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article  \nThe Level of Antibodies to Tumor-Associated Glycans in Gastric Cancer Patients Is Lower than in Healthy Donors and Reduces with Age  \nMaxim P. Nikulin 1, *,†, Alexander D. Lipatnikov 2, Alexei Yu. Nokel 3, Svetlana M. Polyakova 2, Svetlana V. Tsygankova 2, Galina V. Pazynina 2, Alexandra V. Semyanikhina 1,4, Elena V. Ogorodnikova 1, Dmitry V. Rogozhin 1, Olesya M. Rossomakhina 5, Dmitrii A. Atiakshin 6, Olga I. Patsap 6, Ivan S. Stilidi 1, Nicolai V. Bovin 2, Igor Buchwalow 6,7, Markus Tiemann 7 and Nadezhda V. Shilova 2,3,†  \nAcademic Editor: Hidekazu Suzuki  \nReceived: 20 November 2025  \nRevised: 8 January 2026  \nAccepted: 9 January 2026  \nPublished: 13 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Federal State Budgetary Institution “National Medical Research Center of Oncology Named After N.N.  \nBlokhin” of the Ministry of Health of the Russian Federation, 23, Kashirskoe Shosse, Moscow 115522, Russia;  \n[alexandra_silina@mail.ru](alexandra_silina@mail.ru) (A.V.S.); [ogorodnikovaelena@yandex.ru](ogorodnikovaelena@yandex.ru) (E.V.O.); [d.rogozhin@ronc.ru](d.rogozhin@ronc.ru) (D.V.R.);  \n[i.stilidi@front.ru](i.stilidi@front.ru) (I.S.S.)  \n2 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 16/10, Miklukho-Maklaya Street, Moscow 117997, Russia; [alex.9508@yandex.ru](alex.9508@yandex.ru) (A.D.L.); [smpolyak@googlemail.com](smpolyak@googlemail.com) (S.M.P.); [svlush@mail.ru](svlush@mail.ru) (S.V.T.); [pazininagv@gmail.com](pazininagv@gmail.com) (G.V.P.); [professorbovin@yandex.ru](professorbovin@yandex.ru) (N.V.B.); [pumatnv@gmail.com](pumatnv@gmail.com) (N.V.S.)  \n3 Federal State Budgetary Institution “National Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov” of the Ministry of Health of the Russian Federation, 4, Oparina Street, Moscow 117997, Russia; [anokel@internet.ru](anokel@internet.ru)  \n4 Federal State Budgetary Scientific Institution “Research Centre of Medical Genetics”, 1, Moskvorechye Street, Moscow 115522, Russia  \n5 Federal State Budgetary Educational Institution of Higher Education “Lugansk State Medical University Named After St. Luke” of the Ministry of Health of the Russian Federation, 1G, Quarter of the  \n50th Anniversary of the Defense of Lugansk, Lugansk 291045, Russia; [lesya_ros@mail.ru](lesya_ros@mail.ru)  \n6 Research and Educational Resource Center for Immunophenotyping, Digital Spatial Profiling and Ultrastructural Analysis Innovative Technologies, Peoples’ Friendship University of Russia, 6, Miklukho-Maklaya Str., Moscow 117198, Russia; atyakshin-da@rudn.ru (D.A.A.); olga@patsap.ru (O.I.P.); [buchwalow@pathologie-hh.de](buchwalow@pathologie-hh.de) (I.B.)  \n7 Institute for Hematopathology, Fangdieckstr, 75a, 22547 Hamburg, Germany; [mtiemann@hp-hamburg.de](mtiemann@hp-hamburg.de)  \n* [Correspondence: maximpetrovich@mail.ru](Correspondence: maximpetrovich@mail.ru); Tel.: +7-903-169-31-88 † These authors contributed equally to this work.  \nAbstract  \nA key function of naturally occurring antibodies is to control pathologically altered cells, such as those with aberrant glycosylation. Age-related diminution in the pool of B cells producing these immunoglobulins is linked to impaired anti-tumor immunity. In this study, the levels of antibodies against tumor-associated carbohydrate antigens (TACAs)—common in gastric cancer (GC) and other malignancies—were analyzed in 235 treatmentnaïve GC patients (stages I–IV) and 76 healthy donors using a printed glycan array (PGA) . We found that anti-glycan IgM levels, but not IgG, reduced with age in both patients and donors. Crucially, IgM levels against most glycans were significantly lower in the GC cohort compared with healthy donors, a trend that remained after age adjustment. Furthe","cbCaisOKFdtWPqL0","https://ap.wps.com/l/cbCaisOKFdtWPqL0","pdf",1752884,17,"English","# Abstract\n# Introduction","[{\"question\":\"How were anti-tumor glycan antibodies measured in the study?\",\"answer\":\"The study analyzed antibody levels against tumor-associated carbohydrate antigens in gastric cancer patients and healthy donors using a printed glycan array.\"},{\"question\":\"Which antibody class changes with age, and how does it differ between patients and donors?\",\"answer\":\"Anti-glycan IgM levels, but not IgG, reduce with age in both patients and donors; most IgM specificities are significantly lower in gastric cancer patients even after age adjustment.\"},{\"question\":\"What do the immunohistochemistry results suggest about Tn antibodies in gastric cancer?\",\"answer\":\"Anti-GalNAcα (Tn) antibodies bound tumor cells and showed perinuclear and membrane staining in non-tumor surface cells within the same organ, supporting reduced anti-glycan IgM involvement in early recognition of transformed cells.\"}]","The Level of Antibodies to Tumor-Associated Glycans in Gastric Cancer Patients Is Lower than in Healthy Donors and Reduces with Age | PDF",1790098802,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5aa9837b441003179f897bc3856e6996.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a622757091bf93bee1666f718da49392.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/504940482316b90ea58a0a72c374c072.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c00f4a3c4ef0f5dc89af86078f5e6c4e.webp",980,1385]